Objective
To report our center’s experience in the surgical treatment of ventricular
reconstruction, an effective and efficient technique that allows patients
with end-stage heart failure of ischemic etiology to have clinical
improvement and increased survival.
Methods
Observational, clinical-surgical, sequential, retrospective study. Patients
with ischemic cardiomyopathy and left ventricular aneurysm were attended at
the Heart Failure, Ventricular Dysfunction and Cardiac Transplant outpatient
clinic of the Dante Pazzanese Cardiology Institute, from January 2010 to
December 2016. Data from 34 patients were collected, including systemic
arterial hypertension, ejection fraction, New York Heart Association (NYHA)
functional classification (FC), European System for Cardiac Operative Risk
Evaluation (EuroSCORE) II value, Society of Thoracic Surgeons (STS) score,
ventricular reconstruction technique, and survival.
Results
Overall mortality of 14.7%, with hospital admission being 8.82% and late
death being 5.88%. Total survival rate at five years of 85.3%. In the
preoperative phase, NYHA FC was Class I in five patients, II in 18, III in
eight, and IV in three
vs
. NYHA FC Class I in 17 patients,
II in eight, III in six, and IV in three, in the postoperative period.
EuroSCORE II mean value was 6.29,
P
≤0.01; hazard
ratio (HR) 1.16 (95% confidence interval [CI] 1.02-1.31). STS
mortality/morbidity score mean value was 18.14,
P
≤0.004; HR 1.19 (95% CI 1.05-1.33). Surgical
techniques showed no difference in survival among Dor 81%
vs
. Jatene 91.7%.
Conclusion
Surgical treatment of left ventricular reconstruction in candidates for heart
transplantation is effective, efficient, and safe, providing adequate
survival.